EMERYVILLE, Calif.--(BUSINESS WIRE)--Jack O’Reilly, Sr. VP of Corp. and Business Development of NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY), a clinical stage biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial, fungal, and viral infections, will present at the BIO International convention in San Diego, California, on June 18, 2008 at 1:30PT. The BIO International Convention (BIO) is a symposium including leading pharmaceutical and biotechnology companies presenting to institutional investors, portfolio managers, analysts, and the media, to discuss emerging trends in the sector.
